Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference

21.05.2024 - Baseline characteristics reflect a PAH population with significant disease Topline data from Phase 2b portion of IMPAHCT study to be released in June 2024 Enrollment into the Phase 3 portion of IMPAHCT continues at more than 120 sites globally ... Seite 1

Related Keywords

San Diego ,California ,United States ,American ,Hunter Gillies ,International Conference ,World Health Organization ,Nasdaq ,Aerovate Therapeutics Inc ,American Thoracic Society ,Chief Medical Officer ,